Nukkleus Inc. (NASDAQ:NUKK - Get Free Report) shares traded down 10.1% during mid-day trading on Monday . The company traded as low as $16.50 and last traded at $18.00. 355,335 shares were traded during mid-day trading, a decline of 75% from the average session volume of 1,396,463 shares. The stock had previously closed at $20.02.
Wall Street Analyst Weigh In
Separately, Wall Street Zen raised Nukkleus from a "sell" rating to a "hold" rating in a report on Friday.
Read Our Latest Research Report on Nukkleus
Nukkleus Stock Down 1.4%
The stock has a fifty day simple moving average of $14.79 and a 200-day simple moving average of $16.54.
Nukkleus (NASDAQ:NUKK - Get Free Report) last released its earnings results on Friday, May 23rd. The company reported $18.19 earnings per share (EPS) for the quarter.
Institutional Trading of Nukkleus
An institutional investor recently bought a new position in Nukkleus stock. Compagnie Lombard Odier SCmA acquired a new position in Nukkleus Inc. (NASDAQ:NUKK - Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The firm acquired 6,200 shares of the company's stock, valued at approximately $74,000. Compagnie Lombard Odier SCmA owned 0.13% of Nukkleus at the end of the most recent quarter. 12.47% of the stock is currently owned by hedge funds and other institutional investors.
Nukkleus Company Profile
(
Get Free Report)
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors.
Featured Articles
Before you consider Nukkleus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nukkleus wasn't on the list.
While Nukkleus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
